In the field of nuclear medicine in particular, FAP appears to be a promising target due to its non-expression in normal fibroblasts and the stroma of benign epithelial tumors compared to its significantly high accumulation, mainly on the stromal compartments of a variety of malignant tumors [13]. The gene discussed is FAP; the disease is cancer.